162 related articles for article (PubMed ID: 31881137)
1. Female Genital Schistosomiasis.
Hotez PJ; Engels D; Gyapong M; Ducker C; Malecela MN
N Engl J Med; 2019 Dec; 381(26):2493-2495. PubMed ID: 31881137
[No Abstract] [Full Text] [Related]
2. Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review.
Stecher CW; Kallestrup P; Kjetland EF; Vennervald B; Petersen E
Int J Public Health; 2015 Nov; 60(7):839-48. PubMed ID: 26298443
[TBL] [Abstract][Full Text] [Related]
3. Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.
Hotez PJ; Harrison W; Fenwick A; Bustinduy AL; Ducker C; Sabina Mbabazi P; Engels D; Floerecke Kjetland E
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007025. PubMed ID: 30946746
[No Abstract] [Full Text] [Related]
4. Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission.
Ofoezie IE
Acta Trop; 2000 Feb; 75(1):123-6. PubMed ID: 10708014
[No Abstract] [Full Text] [Related]
5. A review of female genital schistosomiasis.
Kjetland EF; Leutscher PD; Ndhlovu PD
Trends Parasitol; 2012 Feb; 28(2):58-65. PubMed ID: 22245065
[TBL] [Abstract][Full Text] [Related]
6. Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment.
Kjetland EF; Ndhlovu PD; Kurewa EN; Midzi N; Gomo E; Mduluza T; Friis H; Gundersen SG
Am J Trop Med Hyg; 2008 Jul; 79(1):79-83. PubMed ID: 18606767
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report.
Richter J; Poggensee G; Kjetland EF; Helling-Giese G; Chitsulo L; Kumwenda N; Gundersen SG; Deelder AM; Reimert CM; Haas H; Krantz I; Feldmeier H
Acta Trop; 1996 Dec; 62(4):289-301. PubMed ID: 9028413
[TBL] [Abstract][Full Text] [Related]
8. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso.
Koukounari A; Gabrielli AF; Toure S; Bosque-Oliva E; Zhang Y; Sellin B; Donnelly CA; Fenwick A; Webster JP
J Infect Dis; 2007 Sep; 196(5):659-69. PubMed ID: 17674306
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma haematobium.
Reich MR; Fenwick A
N Engl J Med; 2001 Apr; 344(15):1170. PubMed ID: 11302148
[No Abstract] [Full Text] [Related]
10. Schistosomal appendicitis.
Adehossi E; Parola P
Lancet Infect Dis; 2004 Aug; 4(8):498. PubMed ID: 15288822
[No Abstract] [Full Text] [Related]
11. The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa.
Norseth HM; Ndhlovu PD; Kleppa E; Randrianasolo BS; Jourdan PM; Roald B; Holmen SD; Gundersen SG; Bagratee J; Onsrud M; Kjetland EF
PLoS Negl Trop Dis; 2014; 8(11):e3229. PubMed ID: 25412334
[TBL] [Abstract][Full Text] [Related]
12. Minimal change glomerulonephritis associated with Schistosoma hematobium infection--resolution with praziquantel treatment.
Turner I; Ibels LS; Alexander JH; Harrison A; Moir D
Aust N Z J Med; 1987 Dec; 17(6):596-8. PubMed ID: 3128971
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa.
Zida A; Briegel J; Kabré I; Sawadogo MP; Sangaré I; Bamba S; Yacouba A; Ouédraogo A; Yonli D; Drabo F; Traoré LK; Ouédraogo-Traoré R; Guiguemdé RT; Wacker J
Infect Dis Poverty; 2016 Sep; 5(1):81. PubMed ID: 27581074
[TBL] [Abstract][Full Text] [Related]
14. [Genital schistosomiasis--diagnosis and therapy].
Elling D; Kupferschmidt HG
Zentralbl Gynakol; 1988; 110(11):671-6. PubMed ID: 3137734
[TBL] [Abstract][Full Text] [Related]
15. Female genital schistosomiasis: facts and hypotheses.
Poggensee G; Feldmeier H
Acta Trop; 2001 Jun; 79(3):193-210. PubMed ID: 11412803
[TBL] [Abstract][Full Text] [Related]
16. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel.
Kjetland EF; Mduluza T; Ndhlovu PD; Gomo E; Gwanzura L; Midzi N; Mason PR; Friis H; Gundersen SG
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):740-52. PubMed ID: 16406034
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
Kovač J; Vargas M; Keiser J
Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
Mutapi F; Ndhlovu PD; Hagan P; Spicer JT; Mduluza T; Turner CM; Chandiwana SK; Woolhouse ME
J Infect Dis; 1998 Jul; 178(1):289-93. PubMed ID: 9652458
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody against Schistosoma haematobium soluble egg antigen: efficacy for diagnosis and monitoring of cure of S. haematobium infection.
Salah F; Demerdash Z; Shaker Z; El Bassiouny A; El Attar G; Ismail S; Badir N; El Din AS; Mansour M
Parasitol Res; 2000 Jan; 86(1):74-80. PubMed ID: 10669141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
